RPAM
Rhenman & Partners Asset Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,924
| Closed | -$443K | – | 101 |
|
|
2025
Q1 | $443K | Sell |
25,924
-119,076
| -82% | -$2.04M | 0.05% | 94 |
|
|
2024
Q4 | $3.59M | Sell |
145,000
-98,000
| -40% | -$2.43M | 0.37% | 64 |
|
|
2024
Q3 | $6.93M | Buy |
243,000
+112,500
| +86% | +$3.21M | 0.56% | 56 |
|
|
2024
Q2 | $3.45M | Buy |
130,500
+5,000
| +4% | +$132K | 0.33% | 68 |
|
|
2024
Q1 | $4.05M | Sell |
125,500
-20,561
| -14% | -$664K | 0.38% | 57 |
|
|
2023
Q4 | $6.15M | Sell |
146,061
-20,000
| -12% | -$843K | 0.61% | 53 |
|
|
2023
Q3 | $6.38M | Buy |
166,061
+66,061
| +66% | +$2.54M | 0.69% | 43 |
|
|
2023
Q2 | $1.9M | Buy |
+100,000
| New | +$1.9M | 0.2% | 75 |
|